Results 211 to 220 of about 2,080,160 (309)

Annual Reports to the ESA Council ESA 110th Annual Meeting July, 2025

The Bulletin of the Ecological Society of America, EarlyView.
wiley   +1 more source

PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature

Clinical Pharmacology &Therapeutics, EarlyView.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou, Estella S. Poloni, José A.G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin, David W. Hein, Sotiria Boukouvala, Andrea Gaedigk   +14 more
wiley   +1 more source

Genetic Diversity Analysis of Cotton Cultivars Using a 40K Liquid Chip in Northern Xinjiang. [PDF]

Int J Mol Sci
Zheng Z, Wang N, Jin S, Ning K, Feng G, Gao H, Si Z, Zhang T, Ai N.   +8 more
europepmc   +1 more source

Promoting Sustainability in Healthcare: Unraveling the Mechanism of Diversity's Impact in the Pharmaceutical Sector

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Although research on sustainability in the healthcare sector is growing, limited attention has been paid to how pharmaceutical companies can be motivated to engage more actively in achieving net‐zero healthcare goals. This study argues that the breadth of directors' experiences—across educational, industrial, and organizational domains—can ...
Ruixin Su, Jianguo Du, Si Li
wiley   +1 more source

Fifteen millennia of human mitogenome evolution in Sicily. [PDF]

Sci Adv
Tommasi A, Boscolo Agostini R, Villani G, Rambaldi Migliore N, Vizzari MT, Cardinali I, Di Gerlando R, Nicolini V, Sorasio G, Santos P, Olivieri A, Perego UA, Catalano G, Volante N, Sarti L, Caramelli D, Sineo L, Lancioni H, Modi A, Ghirotto S, Achilli A.   +20 more
europepmc   +1 more source

To What Extent Does ESG Performance Influence Board Engagement in Acquisition Activity?

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study examines the relationship between boards and corporate acquisition activity. Specifically, we posit that boards with directors who have been politicians positively influence the propensity to pursue acquisitions and that ESG performance (divided into environmental, social, and governance scores) moderates this relationship.
Leticia Pérez‐Calero, Santiago Kopoboru Aguado, Gloria Cuevas‐Rodríguez, Jaime Guerrero Villegas, Pilar Giráldez‐Puig   +4 more
wiley   +1 more source

Assertiveness in Emergency Medicine: Strengthening Communication and Leadership Under Pressure. [PDF]

J Acute Med
Chi CH.
europepmc   +1 more source

Bibliometric Analysis of Technological Innovation in Renewable Energy in the Transport and Logistics Sector

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study conducts a comprehensive bibliometric analysis of technological innovation in renewable energy for the transport and logistics sector from 1996 to 2024. Using the Web of Science database, we identify three main research phases and map key collaboration networks and technological trends.
Yui‐yip Lau, Qiong Chen, Leila Kamalian, Mark Ching‐Pong Poo, Yang Andrew Wu   +4 more
wiley   +1 more source

Where Tech Meets the SDGs: A Supply‐Chain Process Map for Sustainability Management

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study investigates how advanced technologies support Sustainable Development Goals (SDGs) within supply chain management (SCM) through a structured analysis of 4448 sustainable practices. By integrating perspectives from sustainability‐oriented innovation (SOI) and contingent dynamic capabilities, the research conceptualizes technology ...
Vincenzo Varriale, Antonello Cammarano, Moacir Godinho‐Filho   +2 more
wiley   +1 more source

Market Perceptions of ESG Reputational Risk in the US Pharmaceutical Industry

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Negative ESG‐related reputational events generate significant corporate risks, particularly within sensitive sectors such as the pharmaceutical industry. Using novel reputational data, this research investigates investor perceptions of the consequences of experienced ESG breaches among US pharmaceutical firms.
Erdinc Akyildirim, Shaen Corbet, Jose Antonio Muñiz, Frank Scrimgeour   +3 more
wiley   +1 more source